Education
  • Featured content
    In this interactive, CME-certified module, Dipen Maru, MD, provides his perspective on how to leverage biomarkers of response to immune checkpoint inhibitors to optimize the care of patients with colorectal cancer.
  • Featured content
    Anas Younes, MD, discusses standards of care for patients with or at risk of TLS, including risk stratification and optimal use of available agents for prophylaxis and treatment of TLS.
  • Featured content
    Richard Finn, MD; Gary K. Schwartz, MD; and Geoffrey Shapiro, MD, PhD, discuss the supporting rationale and emerging role of selective CDK4/6 inhibitors in multiple types of cancer.
  • Featured content
    Get the most recent clinical data informing the optimal use of VEGF-targeted therapies in colorectal cancer, gastric and GEJ cancer, HCC, and GIST.
  • Featured content
    In this CME/CE-certified module, Jae H. Park, MD, discusses the association of novel anticancer agents with cytokine release syndrome and reviews optimal current assessment, prevention, and treatment.
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Educational Activities

10 of 262 Shown
10 of 262 Shown
Show 10 More
Loading...